Selective inhibitors of GSK-3β: a suitable therapy for Down syndrome?
Giacomini, A., Stagni, F., Emili, M., Guidi, S., Salvalai, M.E., Vidal-Sanchez, V., Grilli, M., Martinez-Cuè Pesini, C., Bartesaghi, R.Volume:
28
Language:
english
Journal:
European Neuropsychopharmacology
DOI:
10.1016/j.euroneuro.2017.12.105
Date:
March, 2018
File:
PDF, 61 KB
english, 2018